MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > FDA can't possibly turn down REVEALCOVID19

<< Previous

Bullboard Posts

Next >>

Comment by Nathaniel13on Dec 11, 2020 9:26am

63 Views

Post# 32087249

RE:RE:RE:FDA can't possibly turn down REVEALCOVID19

Petey you started out so innocent, what happened pal? Are you hedging your bets (invested here) but always bashing so that if prices rise, you make money but look foolish, or if prices fall you lose money but look smart?

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China